Matches in Nanopublications for { ?s ?p "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP88222.RAR1YfCCltWVcdn1BFyjDsCDl2lgUkb-py1NxiqoQlmfI130_assertion description "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88222.RAR1YfCCltWVcdn1BFyjDsCDl2lgUkb-py1NxiqoQlmfI130_provenance.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion description "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.
- NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_assertion description "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227241.RAZR2Lua37HZcQkwyWBfrn_WcAUMWYhXFZZo0kIg1y9zM130_provenance.